Kennedy MC, Hayashi K, Milloy MJ, Boyd J, Wood E, Kerr T Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: a gender-based analysis Int J Drug Policy, 2020. PubMed


Prangnell A, Shoveller J, Voon P, Shulha H, Grant C, Milloy MJ, Kerr T, Hayashi K The impact of childhood emotional abuse on pain interference among people with chronic pain who inject drugs in Vancouver, Canada Pain Med, 2020. PubMed


Boyd J, Lavalley J, Czechaczek S, Mayer S, Kerr T, Maher L, McNeil R "Bed Bugs and Beyond": an ethnographic analysis of North America's first women-only supervised drug consumption site Int J Drug Policy, 2020. PubMed


Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis Harm Reduct J, 2020. PubMed


Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep, 2020. PubMed


Lavalley J, Kastor S, Tourangeau M, Western Aboriginal Harm Reduction Society, Goodman A, Kerr T You just have to have other models, our DNA is different: the experiences of Indigenous people who use illicit drugs and/or alcohol accessing substance use treatment Harm Reduct J, 2020. PubMed


Dahlby L, Kerr T PTSD and opioid use: implications for intervention and policy Subst Abuse Treat Prev Policy, 2020. PubMed


Schwartz C, Fast D, Knight R Poppers, queer sex and a Canadian crackdown: examining the experiences of alkyl nitrite use among young sexual minority men Int J Drug Policy, 2020. PubMed


McNeil R, Puri N, Boyd J, Mayer S, Hayashi K, Small W Understanding concurrent stimulant use among people on methadone: a qualitative study Drug Alcohol Rev, 2020. PubMed


Socías ME, Dong H, Wood E, Brar R, Richardson L, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy in a Canadian setting Int J Drug Policy, 2020. PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use